I’ve met Jesus during June 2023. Jesus works at Bayer Pharmaceuticals currently as the Head of Business Disruption. Love Stranger Things, AcceleRed, TeamRed, Science4Berlin, STEM4Health, Hackathons, Biotech, Digital Health, Startups, Web3, Networking For Health, Science, Technology, Pharma, Exobiology, Space, Science Fiction, Germany, Cuba, you can connect with Jesus in LinkedIn: https://www.linkedin.com/in/yeysus/ Twitter: https://twitter.com/yeysus Web3: yeysus.eth/.tez/.near POAPs collections in Welook.io: Bayer: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/1 Bayer Haemophilia: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/24 Bayer R&D DS&AI: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/25 Bayer R&D DS&AI Posters Madrid: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/26 Bayer Hellas / Greece: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/27 Bayer Product Supply: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/28 Bayer Berlin: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/29 Bayer IT: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/30 Bayer R&D: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/31 Bayer Communities: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/32 Bayer Medical Affairs: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/33

I visited the Byron Bar at the Bayer Pharmaceuticals Headquarters in Berlin during the spring of 2023. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com. Find more information at https://pharma.bayer.com. Facebook: http://www.facebook.com/bayer. Twitter: @BayerPharma. Art by POAP Studio, https://www.poap.studio/. Bayer POAPs terms and conditions: https://bayer.com/poap.

The Bayer Pharma Data Science & Artificial Intelligence (DS&AI) F2F meeting in Madrid was a great event! The motto Connect, Clarify & Commit came to life as we connected during networking sessions, breakout sessions and social events. At the poster session we learned about our progress embedding a product mindset and driving operational excellence, closely collaborating with our partners across R&D. We heard presentations, took part in discussions, unconference sessions, asked questions and shared ideas, setting foundations for the growth of DS&AI beyond 2023. The use of POAPs was a definite social success and I am sure you did not miss Jesús’ enthusiasm as he gave an overview of this new tool. By promoting its use, we drive new ways of using this sustainable and effective tool, ultimately helping to innovate its use by doctors, within clinical trials, for patients and more. There were fun elements as well, like the final night, where our very own flash-mob took to the dance floor and we danced until way past midnight! All this was made possible by the org team: Anke Ebert, Larsen Schnadhorst, Kathleen Thies, Sheila Elz, Stefanie Holt-Noreiks and Claudia Vogt. They have done an excellent job coordinating the event, with the perfect balance of presentations, speakers, entertainment, and networking. Now let us make sure we continue to further the impact we have on bringing innovative medicines to our patients. Sai Jasti, Head of DS&AI https://bayer.com/poap

Experienced leader in development, validation, and implementation of clinical trial software and processes

Scientific work in Pharma R&D requires a reliable high-quality body of data and knowledge. Bayer Pharma R&D has an extremely large amount of scientific data. The use of a Data Catalog significantly improves the findability of data and serves as a key pillar in the implementation of a comprehensive data strategy.